Biopact is a Molecular Rebar Design Company focusing on nanoscale biomaterials company developing the MGMR intracellular delivery vehicle. MGMR is a cellular-engineering tool for biomanufacturing and agricultural processes which value efficient delivery of RNAs, peptides, and genetic materials.
MGMR is a highly-efficient intracellular delivery vehicle, consisting of a stabile dispersion of hollow, nanoscale tubules approximately 1/10,000th the width of a human hair. The high aspect-ratio, nanoscale profile of MGMR allows it to readily penetrate cells without compromising membrane integrity or inducing cytotoxicity. Its high surface-to-volume ratio and tunable surface chemistry allow it to readily transport both small and large-molecular payloads into the cytoplasm, including growth factors, oligonucleotides, proteins and gene-editing complexes.
Biopact has evaluated the cytotoxicity profile of MGMR across multiple cell-lines and investigated safety and efficacy in murine biodistribution and clearance models. Our in vivo studies demonstrate that MGMR is biologically-inert, well-tolerated and rapidly cleared from non-targeted tissues. In a murine therapeutic model, MGMR loaded with doxorubicin (Dox) demonstrated a remarkable capability to rapidly concentrate drug in targeted tissues and extend half-life of its molecular cargo.
Promising assessments of intracellular delivery performance in different eukaryotic cell-types suggest the potential for developing MGMR as a biomolecular delivery vehicle for various expression platforms and cell-factories of interest to agricultural and industrial applications, including mammalian cell-lines, yeasts, bacteria and plants. Robust cellular uptake observed with MGMR offers the potential to deliver molecular payloads to difficult-to-penetrate cell-types or those acutely sensitive to detergents and other conventional methods for transmembrane delivery.
Company Details
- Employees
- 4
- Founded
- 2014
- Address
- 12310 Trail Driver Street, Austin,texas 78737,united States
- Phone
- 800.561.7087
- in****@****act.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bio-pact.com
- Keywords
- intracellular delivery, gene delivery, protein delivery, antibody delivery, RNAi, drug delivery, genetic engineering, strain development, agricultural bioengineering, genetically modified organisms, cellular delivery, trans-membrane delivery, nanotechnology.
- HQ
- Austin, Texas
Biopact Questions
Biopact's helpline number is 800.561.7087
Biopact's website is bio-pact.com
Biopact's LinkedIn profile is https://www.linkedin.com/company/bio-pact
Biopact has
4 employees.
View email and phone details for 4
employees at Biopact.
Biopact's industry is
Biotechnology Research
Biopact's top competitors are
Cna International Usa,
Biopact,
Celling Biosciences,
Actuate Therapeutics, Inc.,
Tvardi Therapeutics,
Renibus Therapeutics Inc,
Lumos Pharma,
Everlume Bio,
Colossal Biosciences,
Ayuvis Research, Inc..
Biopact's support email address is inquiries@bio-pact.com
Biopact's categories are Biotechnology Research
Biopact's founding year is 2014
